Clinical Research

The Power of Positive Thinking

A recent meta-analysis suggests that treating some of the psychological complications of multiple sclerosis may have a positive effect on physical symptoms as well

Multiple sclerosis is a disease that eats away not only at a person’s physical capabilities, but also...

Clinical Research, People

MRI Education May Benefit MSers

People with MS often feel anxious about MRIs and frequently lack basic knowledge of this diagnostic procedure. Is an education program that creates “expert patients” the answer?

Persons with multiple sclerosis often feel stressed while in the magnetic resonance imaging scanner and then...

Clinical Research, People

MS Research Roundup: December 2, 2014

Fingolimod Falls Short for PPMS; Expanded U.S. Clinical Trial Data; New Neuroinflammatory T Cell Subset; Writing With Style

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Drug Development, Laboratory Research

Dorsiflexion Assist Orthosis Helps MSers Walk

The Foot-Up dorsiflexion assist orthosis

Researchers in Australia recently tested the dorsiflexion assist orthosis, better known as the Foot-Up, in a randomized crossover trial. They found that the device helped improve strength and reduce the physiological cost of walking, but that patients still felt as fatigued as they did without the device.

Progressive physical disability is a grim reality for people living with...

Clinical Research

Does Diet Matter in Multiple Sclerosis?

Diet is the ever-moving target in MS research. In this story, we’ll look at the facts, fiction, and continued struggles of researching dietary contributions to multiple sclerosis.

Every morning, “V” starts her day with “bulletproof coffee”: coffee blended with butter and coconut oil. Then she...

Clinical Research, Laboratory Research, Methods, People

MS Research Roundup: November 21, 2014

Gulf War–Era MS Veterans; Modafinil Performance Questioned; More Reproducible Findings; MS in Movies and TV

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Laboratory Research, People

DMT Discontinuation Review Stirs MS Research Community

The U.S. Agency for Healthcare Research and Quality (AHRQ) recently released a draft review on the evidence on discontinuation of disease-modifying therapies. Shocked by the apparent lack of expertise in the first draft, MS researchers and advocacy groups sent in a wave of comments chastising the AHRQ for the perceived shoddiness of the report.

A draft review of the evidence surrounding discontinuation of disease-modifying therapies has sparked...

Clinical Research, Methods